H. Seidel

H.
Martin Seidel currently works at IFM Therapeutics LLC, as Chief Executive Officer & Director from 2019, IFM Cinque, Inc., as Chief Executive Officer, IFM Continua, Inc., as Chief Executive Officer, IFM Quattro, Inc., as Chief Executive Officer, Third Harmonic Bio, Inc., as Independent Director from 2019, and Atlas Venture Advisors, Inc., as Advisor.
Dr. Seidel also formerly worked at DuPont Pharmaceuticals Co., as Director from 2001 to 2003, Novartis Institute for Functional Genomics, Inc., as Institute Director, Novartis Institute for Functional Genomics, Inc., as Director-Institute & Site Head from 2010 to 2014, and Novartis Institutes for Biomedical Research, Inc., as Global Head-Strategic Alliances from 2014 to 2017.
Dr. Seidel received his doctorate degree in 1992 from Harvard University and undergraduate degree in 1986 from Princeton University.